Logo image of REV

REVLON INC-CLASS A (REV) Stock Fundamental Analysis

NYSE:REV - New York Stock Exchange, Inc. - US7615256093 - Common Stock - Currency: USD

3.8999  -0.22 (-5.34%)

Fundamental Rating

2

REV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. While REV seems to be doing ok healthwise, there are quite some concerns on its profitability. REV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year REV has reported negative net income.
In the past year REV has reported a negative cash flow from operations.
REV Yearly Net Income VS EBIT VS OCF VS FCFREV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA -15.41%
ROE N/A
ROIC 8.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REV Yearly ROA, ROE, ROICREV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20 30

1.3 Margins

REV's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.37%
PM (TTM) -18.74%
GM N/A
OM growth 3YN/A
OM growth 5Y-8.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
REV Yearly Profit, Operating, Gross MarginsREV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

REV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
REV has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, REV has a worse debt to assets ratio.
REV Yearly Shares OutstandingREV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
REV Yearly Total Debt VS Total AssetsREV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B

2.2 Solvency

REV has an Altman-Z score of -0.60. This is a bad value and indicates that REV is not financially healthy and even has some risk of bankruptcy.
REV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.6
ROIC/WACC1.16
WACC7.62%
REV Yearly LT Debt VS Equity VS FCFREV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 1B -1B 2B -2B 3B

2.3 Liquidity

A Current Ratio of 1.23 indicates that REV should not have too much problems paying its short term obligations.
REV has a Quick Ratio of 1.23. This is a bad value and indicates that REV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.75
REV Yearly Current Assets VS Current LiabilitesREV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

More info and screens

2

3. Growth

3.1 Past

REV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -124.11%.
REV shows a small growth in Revenue. In the last year, the Revenue has grown by 0.61%.
The Revenue has been decreasing by -2.29% on average over the past years.
EPS 1Y (TTM)-124.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-308.91%
Revenue 1Y (TTM)0.61%
Revenue growth 3Y-6.76%
Revenue growth 5Y-2.29%
Sales Q2Q%-11.02%

3.2 Future

REV is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.58% yearly.
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y-39.42%
EPS Next 2Y-19.36%
EPS Next 3Y-11.19%
EPS Next 5Y-7.58%
Revenue Next Year3.47%
Revenue Next 2Y4.29%
Revenue Next 3Y3.95%
Revenue Next 5Y4.04%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
REV Yearly Revenue VS EstimatesREV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
REV Yearly EPS VS EstimatesREV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

REV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REV Price Earnings VS Forward Price EarningsREV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.77
REV Per share dataREV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

A cheap valuation may be justified as REV's earnings are expected to decrease with -11.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.36%
EPS Next 3Y-11.19%

More info and screens

0

5. Dividend

5.1 Amount

REV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REVLON INC-CLASS A

NYSE:REV (10/20/2022, 8:11:10 PM)

3.8999

-0.22 (-5.34%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-09 2022-08-09/bmo
Earnings (Next)11-08 2022-11-08/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners2.12%
Ins Owner Change0%
Market Cap228.40M
Analysts45
Price Target8.67 (122.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-90.75%
Min EPS beat(2)-213.1%
Max EPS beat(2)31.59%
EPS beat(4)3
Avg EPS beat(4)80%
Min EPS beat(4)-213.1%
Max EPS beat(4)461.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.41%
Min Revenue beat(2)-13.62%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-6.66%
Min Revenue beat(4)-13.62%
Max Revenue beat(4)-1.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 1.77
EPS(TTM)-5.67
EYN/A
EPS(NY)-4.22
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS35.15
BVpS-40.09
TBVpS-55.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE N/A
ROCE N/A
ROIC 8.86%
ROICexc N/A
ROICexgc 21.69%
OM 8.37%
PM (TTM) -18.74%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-1.54%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-8.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.75
Altman-Z -0.6
F-Score4
WACC7.62%
ROIC/WACC1.16
Cap/Depr(3y)12.1%
Cap/Depr(5y)27.62%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-124.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-308.91%
EPS Next Y-39.42%
EPS Next 2Y-19.36%
EPS Next 3Y-11.19%
EPS Next 5Y-7.58%
Revenue 1Y (TTM)0.61%
Revenue growth 3Y-6.76%
Revenue growth 5Y-2.29%
Sales Q2Q%-11.02%
Revenue Next Year3.47%
Revenue Next 2Y4.29%
Revenue Next 3Y3.95%
Revenue Next 5Y4.04%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.53%
OCF growth 3YN/A
OCF growth 5YN/A